Lupeol alters ER stress-signaling pathway by downregulating ABCG2 expression to induce Oxaliplatin-resistant LoVo colorectal cancer cell apoptosis-Reference-Cited by-全球学者库

Lupeol alters ER stress-signaling pathway by downregulating ABCG2 expression to induce Oxaliplatin-resistant LoVo colorectal cancer cell apoptosis

Published:2018-02-13 Issue:5 Volume:33 Page:587-593
ISSN:1520-4081
Container-title:Environmental Toxicology
language:en
Short-container-title:Environmental Toxicology

Author:

Chen Ming-Cheng¹²,Hsu Hsi-Hsien³⁴,Chu Yuan-Yuan⁵,Cheng Sue-Fei⁶,Shen Chia-Yao⁷,Lin Yi-Jiun⁵,Chen Ray-Jade⁸,Viswanadha Vijaya Padma⁹,Lin Yueh-Min¹⁰¹¹,Huang Chih-Yang⁵¹²¹³¹⁴^ORCID

Affiliation:

1. Division of Colorectal Surgery; Taichung Veterans General Hospital; Taichung Taiwan

2. Faculty of Medicine; National Yang-Ming University; Taipei Taiwan

3. Division of Colorectal Surgery; Mackay Memorial Hospital; Taipei Taiwan

4. Mackay Medicine; Nursing and Management College; Taipei Taiwan

5. Graduate Institute of Basic Medical Science, China Medical University; Taichung Taiwan

6. Department of Pharmacy; Veterans General Hospital; Taipei Taiwan

7. Department of Nursing; Mei Ho University, Pingguang Road; Pingtung Taiwan

8. Department of Surgery, School of Medicine, College of Medicine; Taipei Medical University; Taipei Taiwan

9. Department of Biotechnology; Bharathiar University; Coimbatore 641 046 India

10. Department of Pathology; Changhua Christian Hospital; Changhua Taiwan

11. Jen-Teh Junior College of Medicine, Nursing and Management; Miaoli Taiwan

12. Faculty of Applied Sciences; Ton Duc Thang University, Tan Phong Ward, District 7; Ho Chi Minh City 700000 Vietnam

13. Graduate Institute of Chinese Medical Science, China Medical University; Taichung Taiwan

14. Department of Health and Nutrition Biotechnology; Asia University; Taichung Taiwan

Funder

Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Management, Monitoring, Policy and Law,Toxicology,General Medicine

Reference40 articles.

1. Colorectal cancer statistics, 2017;Siegel;CA Cancer J Clin.,2017

2. Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers;Becouarn;J Clin Oncol.,1998

3. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line;Drewinko;Cancer Res.,1976

4. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis;Liang;Chin Med J (Engl).,2010

5. Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer;Peinert;Ther Adv Med Oncol.,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Established anticancer agents from plants;Advances in Botanical Research;2024

2. A review on the mechanisms underlying the antitumor effects of natural products by targeting the endoplasmic reticulum stress apoptosis pathway;Frontiers in Pharmacology;2023-11-17

3. Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier;Journal of Xenobiotics;2023-03-25

4. Amentoflavone induces caspase‐dependent/−independent apoptosis and dysregulates cyclin‐dependent kinase‐mediated cell cycle in colorectal cancer in vitro and in vivo;Environmental Toxicology;2023-02-02

5. Matrine restrains the development of colorectal cancer through regulating the AGRN/Wnt/β‐catenin pathway;Environmental Toxicology;2023-01-09